PROFILE OF PATIENTS WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS AT MERAUKE REGIONAL GENERAL HOSPITAL, MERAUKE REGENCY, SOUTH PAPUA, JANUARY 2021 – DECEMBER 2024
Keywords:
TB MDR, OAT, Character StatisticAbstract
Pulmonary MDR-TB is tuberculosis that is resistant to first-line drugs, especially isoniazid and rifampicin, due to genetic mutations at drug target sites, so it requires combinations of drugs from Groups A and B, and if needed, Group C.
This descriptive study used medical records of MDR-TB patients treated at Merauke Regional Hospital from January 2021 to December 2024 and was analyzed univariately with SPSS version 26. Most patients were 18–59 years old (90.6%), female (53.1%), and had a history of previous TB treatment (89.3%), with a small proportion experiencing treatment interruption and treatment failure. Comorbidities included diabetes mellitus (6.3%) and HIV (18.8%), and the mortality rate was relatively high at 40.6%.
References
Abraham, Y., Assefa, D. G., Hailemariam, T., Gebrie, D., Debela, D. T., Geleta, S. T., ... & Manyazewal, T. (2024). Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis. BMC Infectious Diseases, 24(1), 1087.
Adiwinata, R., Rasidi, J., Marpaung, M., Timur, K., & Timur, K. (2018). Profil klinis dan evaluasi pengobatan pasien rifampicin-resistant dan multidrug-resistant tuberculosis di RSUD dr. Kanujoso Djatiwibowo Balikpapan. J Respir Indo, 38(3), 135-142.
Aminah, N. S., & Djuwita, R. (2021). Trend dan faktor yang berhubungan dengan keberhasilan pengobatan pasien TB MDR paduan jangka pendek di Indonesia 2017-2019. Pro Health Jurnal Ilmiah Kesehatan, 3(1).
Aviana, F., Jati, S. P., & Budiyanti, R. T. (2021). Systematic Review Pelaksanaan Programmatic Management of Drug-Resistant Tuberculosis Pada Pasien Tuberkulosis Resistan Obat. Jurnal Kesehatan Masyarakat, 9(2), 215-222.
Nadeak, B., Manik, J., & Destine, D. (2025). The Effectiveness of Managerial Approaches in Promoting Adolescent Healthy Lifestyles: A Qualitative Study at HKBP Gedong Church. Asian Journal of Basic Science & Research, 7(2), 119-128.
Nunkaidah, M., Lestari, H., & Afa, J. R. (2017). Prevalensi risiko kejadian tuberkulosis multi drug resistance (TB-MDR) di kabupaten muna tahun 2013–2015 (Doctoral dissertation, Haluoleo University).
Nurdin, N. (2020). Analisis faktor-faktor determinan Individu terhadap Tuberculosis Multidrug Resistant (TB MDR) di Provinsi Sumatera Selatan. Jurnal kesehatan komunitas (Journal of community health), 6(1), 63-67.
Rahmawati, B. A., & Lestari, R. (2024). Tuberkulosis Multidrug-Resistant (TB-MDR): Diagnosis and Treatment. Lombok Medical Journal, 3(2), 38-43.
Siahaan, A. G., Polii, E. B., & Ongkowijaya, J. (2016). Profil pasien tuberkulosis dengan multi drug resistance (MDR) di RSUP Prof. Dr. RD Kandou periode Agustus 2015-Agustus 2016. e-CliniC, 4(2).
Sultana, Z. Z., Hoque, F. U., Beyene, J., Akhlak-Ul-Islam, M., Khan, M. H. R., Ahmed, S., ... & Hossain, A. (2021). HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC infectious diseases, 21(1), 51.
Surbakti, S. D. O., & Laksana, I. B. (2021). Strategi Komunikasi Risiko Kementerian Kesehatan Republik Indonesia dalam Upaya Penanggulangan Covid-19 Melalui Media Sosial. Sosioedukasi: Jurnal Ilmiah Ilmu Pendidikan Dan Sosial, 10(2), 217-1228.
Suryavanshi, N., Murrill, M., Gupta, A., Hughes, M., Hesseling, A., Kim, S., ... & Shah, N. S. (2020). Willingness to take multidrug-resistant tuberculosis (MDR-TB) preventive therapy among adult and adolescent household contacts of MDR-TB index cases: an international multisite cross-sectional study. Clinical Infectious Diseases, 70(3), 436-445.
Suwanto, Y. A., Hediningsih, Y., & Hadi, P. (2024). POLA KEPEKAAN OBAT ANTITUBERKULOSIS LINI PERTAMA PADA PASIEN TBC. Jurnal Kesehatan dan Kedokteran, 3(3), 1-5.
Tiberi, S., Utjesanovic, N., Galvin, J., Centis, R., D'Ambrosio, L., van den Boom, M., ... & Migliori, G. B. (2022). Drug resistant TB–latest developments in epidemiology, diagnostics and management. International Journal of Infectious Diseases, 124, S20-S25.
Tola, H. H., Azar, T. O. L., Shojaeizadeh, D., & Garmaroudi, G. (2015). Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iranian journal of public health, 44(1), 1.
Vanino, E., Granozzi, B., Akkerman, O. W., Munoz-Torrico, M., Palmieri, F., Seaworth, B., ... & Tadolini, M. (2023). Update of drug-resistant tuberculosis treatment guidelines: A turning point. International Journal of Infectious Diseases, 130, S12-S15.
